| 000 | 01813 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250516083419.0 | ||
| 264 | 0 | _c20120727 | |
| 008 | 201207s 0 0 eng d | ||
| 022 | _a1445-5994 | ||
| 024 | 7 |
_a10.1111/j.1445-5994.2011.02557.x _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aBalbir-Gurman, A | |
| 245 | 0 | 0 |
_aPneumatosis cystoides intestinalis in scleroderma-related conditions. _h[electronic resource] |
| 260 |
_bInternal medicine journal _cMar 2012 |
||
| 300 |
_a323-9 p. _bdigital |
||
| 500 | _aPublication Type: Case Reports; Journal Article; Review | ||
| 650 | 0 | 4 |
_aAbdomen, Acute _xetiology |
| 650 | 0 | 4 |
_aAdrenal Cortex Hormones _xadverse effects |
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 | _aAged |
| 650 | 0 | 4 |
_aConnective Tissue Diseases _xcomplications |
| 650 | 0 | 4 | _aDiagnosis, Differential |
| 650 | 0 | 4 |
_aDiatrizoate Meglumine _xtherapeutic use |
| 650 | 0 | 4 | _aFatal Outcome |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoalbuminemia _xetiology |
| 650 | 0 | 4 |
_aImmunoglobulins, Intravenous _xtherapeutic use |
| 650 | 0 | 4 |
_aIntestinal Obstruction _xdiagnosis |
| 650 | 0 | 4 |
_aIntestinal Pseudo-Obstruction _xetiology |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aOctreotide _xtherapeutic use |
| 650 | 0 | 4 |
_aOmeprazole _xtherapeutic use |
| 650 | 0 | 4 |
_aPneumatosis Cystoides Intestinalis _xdiagnosis |
| 650 | 0 | 4 |
_aPneumoperitoneum _xetiology |
| 650 | 0 | 4 |
_aPolymyositis _xcomplications |
| 650 | 0 | 4 |
_aScleroderma, Systemic _xcomplications |
| 650 | 0 | 4 |
_aSjogren's Syndrome _xcomplications |
| 650 | 0 | 4 | _aWeight Loss |
| 700 | 1 | _aBrook, O R | |
| 700 | 1 | _aChermesh, I | |
| 700 | 1 | _aBraun-Moscovici, Y | |
| 773 | 0 |
_tInternal medicine journal _gvol. 42 _gno. 3 _gp. 323-9 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1111/j.1445-5994.2011.02557.x _zAvailable from publisher's website |
| 999 |
_c21637173 _d21637173 |
||